Diversified Healthcare Trust reports today with short sellers markedly more pessimistic than they were a month ago, even as the borrow market remains deeply relaxed.
Short interest has jumped 20% over the past 30 days to 5.3% of the free float — a level that earns genuine attention. The move is recent and deliberate: shares short climbed from roughly 10.5 million at the end of June to nearly 12.9 million by July 31, with most of the build concentrated in the second half of July. Yet the borrow market tells a different story about squeeze risk. Availability runs at roughly 1,143% of outstanding short interest — meaning there are more than eleven shares available to borrow for every one currently lent out, well above the 52-week floor of 509%. Cost to borrow is negligible at 0.44%. There is no mechanical pressure forcing shorts to cover. Options positioning has shifted alongside: the put/call ratio is 0.34, about 1.5 standard deviations above its 20-day average of 0.26, pointing to incrementally more defensive positioning. It remains far below the 52-week high of 0.94, so the options market is edgy but not alarmed.
The analyst community has been quietly more constructive. In June, both RBC Capital and B. Riley raised price targets — RBC from $6.00 to $8.00 and B. Riley from $8.50 to $11.00 — while maintaining existing ratings. That optimism runs against a stock trading at $8.81, down 6.4% on the week and 4.6% on the month, underperforming peers. and both fell roughly 7% on the week, so some of the pressure is sector-wide, but DHC has lost ground even within a weak group. The bull case rests on a recovery in senior housing and medical office fundamentals; the bear case points to negative earnings per share, a price-to-book of just 0.21, and an F-score of 2, which flags weak fundamental health. An EV/EBITDA of 13.2x is not cheap for a REIT carrying operational risks of this profile.
Institutional ownership adds a layer of complexity. The top two holders — Flat Footed LLC and RMR Group — each hold close to 9.7% and 9.6% of shares respectively, with neither reporting a change in their last filing. BlackRock added roughly 465,000 shares through June, and State Street added 2.3 million. Passive accumulation is ticking up, but concentrated strategic holders with no recent movement suggest the stock's near-term direction will come from the operating results rather than ownership flows.
Today's print is a test of whether DHC's operational recovery narrative — the one that sent the stock up more than 50% year-to-date before this recent slide — can withstand scrutiny on occupancy trends, medical office leasing, and the timeline to positive earnings.
See the live data behind this article on ORTEX.
Open DHC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
